Cite
HARVARD Citation
Huang, X. et al. (2021). Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial. Journal for immunotherapy of cancer. 9 (5), p. . [Online].